Immunizations Information Systems (IIS) Vaccine Code Set Release Notes

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]




    You are subscribed to one or more CDC code sets email subscription services.


    Release notes: This release does not include updates for Vaccine Information Statement (VIS) codes and maps. Release notes and files for VIS code updates are distributed in separate release cycles.

    General Note regarding this release: Codes with “Last Update” dates after March 11, 2020 reflect the changes and additions in this release. It includes the following code set updates:
    1. CVX Code Updates: Three new CVX codes for Southern Hemisphere influenza have been added:
      1. CVX code 200, “influenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free”
      2. CVX code 201, “influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, no preservative”
      3. CVX code 202, “influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative”
    2. NDC Unit of Sale and Unit of Use Code Updates:
      1.  Four new NDC pairs have been added:

    Sale NDC11

    Sale Proprietary Name

    Sale Labeler

    Use NDC11

    CVX Code

    MVX Code

    49281-0181-25

    FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE

    Sanofi Pasteur Inc.

    49281-0181-00

    200

    PMC

    49281-0320-50

    FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE

    Sanofi Pasteur Inc.

    49281-0320-88

    201

    PMC

    49281-0336-15

    FLUZONE QUADRIVALENT SOUTHERN HEMISPHERE

    Sanofi Pasteur Inc.

    49281-0336-78

    202

    PMC

    63361-0243-10

    VAXELIS

    MCM Vaccine Co.

    63361-0243-58

    146

    PMC

      1. Two NDC pairs have been retired.  The retired VAXELIS NDC pair has been replaced by the new VAXELIS NDC pair above. 

    63361-0245-10

    VAXELIS

    MCM Vaccine Co.

    63361-0245-58

    146

    PMC

    63851-0501-02

    RabAvert

    GSK Vaccines GmbH

    63851-0511-11

    176

    NOV

      1. Two NDC pairs were previously retired in the FDA files we receive. In February, we added end dates to these NDCs to indicate this. However, the NDCs have been re-activated in subsequent FDA files and the end dates removed in this release to indicate that these are now again active.

    49281-0915-01

    VY-VAX

    Sanofi Pasteur Inc.

    49281-0915-58

    37

    PMC

    49281-0915-05

    VY-VAX

    Sanofi Pasteur Inc.

    49281-0915-68

    176

    PMC

      1. NDC description corrections: A correction was made on an inactive NDC flu vaccine for a past season; the generic description field was missing. This updated the date of last update for NDC 66521-0114-02. No action should be needed.


    [Index of Archives]     [NIH News]     [FDA News]     [USDA News]     [Yosemite News]     [Steve's Art]     [SB Lupus]     [STB]
      Powered by Linux